190 related articles for article (PubMed ID: 22233529)
1. Pharmacokinetic profile and pharmacodynamic effects of romifidine hydrochloride in the horse.
Wojtasiak-Wypart M; Soma LR; Rudy JA; Uboh CE; Boston RC; Driessen B
J Vet Pharmacol Ther; 2012 Oct; 35(5):478-88. PubMed ID: 22233529
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamic effects and pharmacokinetic profile of a long-term continuous rate infusion of racemic ketamine in healthy conscious horses.
Lankveld DP; Driessen B; Soma LR; Moate PJ; Rudy J; Uboh CE; van Dijk P; Hellebrekers LJ
J Vet Pharmacol Ther; 2006 Dec; 29(6):477-88. PubMed ID: 17083451
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic profile and behavioral effects of gabapentin in the horse.
Terry RL; McDonnell SM; Van Eps AW; Soma LR; Liu Y; Uboh CE; Moate PJ; Driessen B
J Vet Pharmacol Ther; 2010 Oct; 33(5):485-94. PubMed ID: 20840393
[TBL] [Abstract][Full Text] [Related]
4. Comparison of sedative effects of romifidine following intravenous, intramuscular, and sublingual administration to horses.
Freeman SL; England GC
Am J Vet Res; 1999 Aug; 60(8):954-9. PubMed ID: 10451204
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and selected pharmacodynamics of romifidine following low-dose intravenous administration in combination with exercise to quarter horses.
Knych HK; Stanley SD; McKemie DS; Steinmetz SJ
J Vet Pharmacol Ther; 2017 Oct; 40(5):569-574. PubMed ID: 28097665
[TBL] [Abstract][Full Text] [Related]
6. Clinical effects and pharmacokinetic variables of romifidine and the peripheral α
de Vries A; Pakkanen SA; Raekallio MR; Ekiri A; Scheinin M; Taylor PM; Vainio OM
Vet Anaesth Analg; 2016 Nov; 43(6):599-610. PubMed ID: 26918855
[TBL] [Abstract][Full Text] [Related]
7. The pharmacokinetics of dexmedetomidine administered as a constant rate infusion in horses.
Ranheim B; Risberg ÅI; Spadavecchia C; Landsem R; Haga HA
J Vet Pharmacol Ther; 2015 Feb; 38(1):93-6. PubMed ID: 25229603
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of detomidine following sublingual administration to horses.
Dimaio Knych HK; Stanley SD
Am J Vet Res; 2011 Oct; 72(10):1378-85. PubMed ID: 21962281
[TBL] [Abstract][Full Text] [Related]
9. Development of a romifidine constant rate infusion with or without butorphanol for standing sedation of horses.
Ringer SK; Portier KG; Fourel I; Bettschart-Wolfensberger R
Vet Anaesth Analg; 2012 Jan; 39(1):12-20. PubMed ID: 22151873
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of yohimbine following intravenous administration to horses.
Dimaio Knych HK; Steffey EP; Deuel JL; Shepard RA; Stanley SD
J Vet Pharmacol Ther; 2011 Feb; 34(1):58-63. PubMed ID: 21219345
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of intravenous romifidine and propranolol administered alone or in combination for equine sedation.
Cenani A; Brosnan RJ; Madigan S; Knych HK; Madigan JE
Vet Anaesth Analg; 2017 Jan; 44(1):86-97. PubMed ID: 27426730
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of midazolam after intravenous administration to horses.
Hubbell JA; Kelly EM; Aarnes TK; Bednarski RM; Lerche P; Liu Z; Lakritz J
Equine Vet J; 2013 Nov; 45(6):721-5. PubMed ID: 23489241
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic-pharmacodynamic modelling of the antinociceptive effect of a romifidine infusion in standing horses.
Diez Bernal S; Studer N; Thormann W; Spadavecchia C; Levionnois O
Vet Anaesth Analg; 2020 Jan; 47(1):129-136. PubMed ID: 31810766
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of intravenous and intramuscular buprenorphine in the horse.
Davis JL; Messenger KM; LaFevers DH; Barlow BM; Posner LP
J Vet Pharmacol Ther; 2012 Feb; 35(1):52-8. PubMed ID: 21392040
[TBL] [Abstract][Full Text] [Related]
15. Effects on cardiopulmonary function and oxygen delivery of doses of romifidine and xylazine followed by constant rate infusions in standing horses.
Ringer SK; Schwarzwald CC; Portier KG; Ritter A; Bettschart-Wolfensberger R
Vet J; 2013 Feb; 195(2):228-34. PubMed ID: 22841452
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular effects of romifidine in the standing horse.
Freeman SL; Bowen IM; Bettschart-Wolfensberger R; Alibhai HI; England GC
Res Vet Sci; 2002 Apr; 72(2):123-9. PubMed ID: 12027592
[TBL] [Abstract][Full Text] [Related]
17. Changes in energy metabolism, and levels of stress-related hormones and electrolytes in horses after intravenous administration of romifidine and the peripheral α-2 adrenoceptor antagonist vatinoxan.
Pakkanen SAE; de Vries A; Raekallio MR; Mykkänen AK; Palviainen MJ; Sankari SM; Vainio OM
Acta Vet Scand; 2018 May; 60(1):27. PubMed ID: 29743097
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamic effects of tolazoline following intravenous administration to horses.
Casbeer HC; Knych HK
Vet J; 2013 Jun; 196(3):504-9. PubMed ID: 23321455
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of dexamethasone with pharmacokinetic/pharmacodynamic model of the effect of dexamethasone on endogenous hydrocortisone and cortisone in the horse.
Soma LR; Uboh CE; Luo Y; Guan F; Moate PJ; Boston RC
J Vet Pharmacol Ther; 2005 Feb; 28(1):71-80. PubMed ID: 15720518
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
Zhao RK; Cheng G; Tang J; Song J; Peng WX
Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
